FIRMQUARRYResearch workspace

FIRMQUARRY / COMPANY INTELLIGENCE

['SAMSUNG BIOEPIS NL BV']

Not reported · Verified headquarters unavailable

Track with Pro
Data last updated Oct 22, 2026 · Source: official procurement and company-intelligence sources

General information

Legal name
['SAMSUNG BIOEPIS NL BV']
First / latest observed
Oct 31, 2026 — Oct 31, 2026

One source-backed chronology

Timeline

Business change, facilities, workforce, corporate events, and government activity appear chronologically.

  1. Government
    Award announced

    Suministro de medicamentos biológicos con biosimilares, lote 14 Eculizumab (vía parenteral intravenosa) para el Servicio de Farmacia del Hospital Clínico Universitario de Valladolid, basado en Acuerdo Marco 2025/034, de INGESA "Suministro respetuoso con el medio ambiente de medicamentos biológicos con biosimilares"

    EU_TED · Tenders Electronic DailyEUR 512,490source backed · match auto verifiedcollected Oct 31, 2026Official source ↗

Disclosed procurement context

Government Business

Money leads this view. Values represent disclosed obligations and procurement amounts—not company revenue.

Global government business

Markets and currencies remain separate; incompatible currencies are never summed.

MarketDisclosed valueCurrencyLatest activityProcesses
ESP€512.5KEUROct 30, 20261

Evidence and identifiers

Sources & Coverage

Technical identifiers live here, with retained official links and visible coverage limitations.

Platform coverage →

Source identifiers